If Magazine9h
Protagonist Pictures boards Nicholas Clifford’s ‘One More Shot’, starring Emily Browning
Protagonist Pictures will launch Stan Original rom-com 'One More Shot' for international sales at this year's European Film ...
Truist maintains Buy on Protagonist Therapeutics with $60 target
Truist Securities reiterated its Buy rating and $60.00 price target for Protagonist Therapeutics (NASDAQ:PTGX) shares, which currently trade at $38.78 with a market capitalization of $2.3 billion. The ...
Protagonist Therapeutics (PTGX) Gets a Buy from TD Cowen
In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report), with a ...
Protagonist Therapeutics (PTGX) Receives a Buy from Truist Financial
In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Protagonist Therapeutics (PTGX – Research ...
Screen International18h
Protagonist Pictures boards SXSW romantic comedy ‘One More Shot’ starring Emily Browning (exclusive)
Protagonist Pictures is launching world sales at the EFM on Australian filmmaker Nicholas Clifford time travelling romantic ...
Screen International18h
Protagonist Pictures boards SXSW premiere ‘One More Shot’ starring Emily Browning (exclusive)
Protagonist Pictures is launching world sales at the EFM on time travel romantic comedy One More Shot, starring American Gods’ Emily Browning, ahead of its world premiere at SXSW. Australian filmmaker ...
JMP Securities maintains PTGX stock with $58 target
JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...